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Synthetic biology aims to make the engineering of biology faster and more predictable. In contrast,
systems biology focuses on the interaction of myriad components and how these give rise to the
dynamic and complex behavior of biological systems. Here, we examine the synergies between
these two fields.Biology is the technology of this century.
The potential uses of biology to improve
the human condition and the future
of the planet are myriad. Over the last
century, humans have used biology to
make many useful things, in part based
on discoveries from molecular biology.
In addition, researchers have redesigned
biological systems to test our funda-
mental understanding of their compo-
nents and integrated functions. However,
the complexity and reliability of engi-
neered biological systems still cannot
approach the diversity and richness ex-
hibited by their natural counterparts. It is
then the combined promise of systems
biology and synthetic biology that may
drive transformative advances in our
ability to program biological function.
One recent example of the successful
engineering of a biological system to
address a global challenge in health and
medicine is the creation of microbes that
produce a precursor to the antimalarial
drug artemisinin (Ro et al., 2006). By shift-
ing synthesis from the natural production
host (a plant) to one more optimized for
rapid production times and inexpensive
scale up (a microorganism), researchers
were able to develop a process that en-
abled cheaper supply of this drug, pro-
viding a more accessible cure for a
disease devastating third world countries.
However, the research phase of this
project required an investment of over
$25million and 150 person-years of highly
trained researcher effort. This investment
cannot realistically be replicated for every
chemical or material to which we wouldapply this approach. Instead, imagine
a time when a bioengineer designs a sys-
tem at the computer, orders the neces-
sary DNA encoding the specified system,
and then begins the actual experiment of
turning it into life. Thus, one overarching
goal of synthetic biology is to make the
engineering of biology faster, affordable,
and more predictable.
Biological systems and their underlying
components offer a number of functional
parallels with engineered systems. For
example, biological sensors are exqui-
sitely sensitive; the olfactory system can
detect single odorant molecules and
decode them. Biological systems can
send and receive signals rapidly and in a
highly specific manner. Pathways exist
to sense and respond to the environment.
Plants and microbes can use sunlight as
an energy source. However, biological
systems are also uniquely capable of
self-replication, mutation, and selection,
leading to evolution. Synthetic biologists
aim to take advantage of these parallels
and develop engineering principles for
the design and construction of biological
systems. However, an open question is
whether we understand biological sys-
tems sufficiently to be able to redesign
them to fulfill specific requirements.
Engineers enjoy the concept of inter-
changeable parts and modularity. Biology
offers many sources of potential modu-
larity but exhibits nonmodular features
as well. For many years the gene was
regarded as a fundamental modular unit
of biology. As such, a gene is capable of
transferring a particular phenotype to theCell 14organism. However, we now know that
genes display more fine-grained modu-
larity in the form of promoters, open
reading frames (ORFs), and regulatory
elements. mRNAs contain sequences
important for proper intracellular targeting
and degradation. Proteins often contain
targeting sequences, reactive centers,
and degradation sequences. And lastly,
entire pathways are modular in that
some signaling pathways can be trans-
ferred from one organism to another to
reconstruct a new state in the engineered
organism. This modularity underlies one
of the core concepts of synthetic bio-
logy—the notion that one can assemble
biological systems from well-defined
‘‘parts’’ or modules (Endy, 2005). How-
ever, modular assembly approaches
have largely remained confounded by
the effects of context—that is, the non-
modular aspects of biology. For example,
where a gene or an associated regulatory
element is located in the genome can
impact expression and thus its function.
In addition, the location of regulatory
elements relative to each other and
ORFs can impact their encoded function
(Haynes and Silver, 2009). Further anal-
yses provided by systems biology may
help to guide the development of stan-
dard strategies for assembling genetic
modules into functional units.
Approaches to Synthetic Biology
Given that the goals of synthetic biology
are to make the engineering of biology
faster and more predictable, and to
harness the power of biology for the4, March 18, 2011 ª2011 Elsevier Inc. 855
common good, the development of new
approaches that support the design and
construction of genetic systems has
been a core activity within the field. Al-
though advances have been made in
both areas (fabrication and design), our
ability to construct large genetic systems
currently surpasses our ability to design
such systems, resulting in a growing
‘‘design gap’’ that is a critical issue that
synthetic biologists must address.
The ability to synthesize large pieces of
DNA corresponding to operons, entire
pathways, chromosomes, and genomes
in a rapid and predictable way is a key
approach to system fabrication. Systems
biology has provided numerous tem-
plates with the abundance of sequenced
genomes being deposited daily into
publicly accessible databases. Some
progress has recently been reported,
including the resynthesis of a bacterial
genome and its successful insertion into
a different bacterial host (Gibson et al.,
2010). However, it took researchers
nearly 15 years and approximately $30
million to develop various fundamental
aspects of this project. Much of this time
and cost was methods development that
will hopefully reduce the resources
needed to carry out such projects in the
future. In addition, new high-throughput
methods for large-scale DNA synthesis
have been recently described (Matzas
et al., 2010; Norville et al., 2010; Tian
et al., 2009). However, much more work
is still needed to develop these technolo-
gies to the point where they are acces-
sible to the majority of researchers (that
is, in terms of cost and reliability), and
systems biology may provide important
clues. For example, faster and more reli-
able ways to synthesize large pieces of
DNA may be uncovered by examination
of new organisms and thereby reveal
new nonchemical methods for DNA
synthesis.
A second approach is to develop the
methods to generate new component
functions that can act as sensors, regula-
tors, controllers, and enzyme activities,
for example. These components will in
turn extend the set of parts from which
synthetic biologists can build genetic
devices and systems. Synthetic biologists
work not only with design of DNA that
encodes genetic circuits but also with
molecular design of biomolecules, such856 Cell 144, March 18, 2011 ª2011 Elsevieras RNAs and proteins, to perform new
functions. Substantial efforts in the field
of protein engineering have contributed
to the diversity of functions exhibited
by protein components (Dougherty and
Arnold, 2009). However, even with these
advances, the diversity of component
activities that is currently available as
parts has been limited, thus limiting
the design of genetic circuits. Systems
biology may aid in the development of
effective strategies for generating new
component functions by providing infor-
mation on how Nature has evolved
different functions for macromolecules.
A third approach is the predictable
design of complex genetic circuits that
lay the foundation for new biological
devices and systems. Many circuits
designed and built thus far have relied
on our fairly detailed knowledge of how
gene transcription is regulated. For
example, synthetic circuits have applied
concepts of positive and negative feed-
back to generate systems that sense
stimuli, remember past events, and pro-
mote cell death in both prokaryotic and
eukaryotic cells (Burrill and Silver, 2010;
Sprinzak and Elowitz, 2005). However,
many of these systems have been built
in a fairly ad hoc manner, requiring sub-
stantial troubleshooting and iterative
design to exhibit desired functions, and
lack the robust performance standards
one might expect as an engineer. Going
forward, synthetic biologists need to
better understand the parts underlying
system design, how to predict their func-
tion in a particular genetic context, and
how to predict their integrated function
with other system parts (Ellis et al., 2009;
Savageau, 2011). This biological under-
standing will then be integrated with com-
putational models to develop computer-
aided design tools.
What Does Systems Biology Mean
to Synthetic Biology?
As with synthetic biology, many different
types of research have been categorized
as systems biology. Broadly speaking,
systems biology represents an approach
to biological research that focuses on
the interactions between components of
a biological system and how those inter-
actions give rise to the dynamic behavior
of the system in contrast to themore tradi-
tional molecular biologists’ reductionistInc.approach of studying components in
isolation from each other (Alon, 2007).
Systems biology has been associated
with new technologies and methods that
allow for quantitative measures of com-
ponents and component interactions
within biological systems, particularly
those that allow for genome-wide mea-
surements. In addition, because many of
these technologies result in large data-
sets, systems biology has also been
associated with computational tools that
support the integration and analysis of
these datasets to identify static relation-
ships and interactions between compo-
nents. Finally, as one of the ultimate goals
of systems biology is to be able to predict
a system’s dynamic behavior from the
component parts, computational tools
that can model biological systems-level
function from underlying components
are associated with this field.
However, there are currently a number
of challenges and limitations facing the
field of systems biology. Paramount is
determining how to correctly analyze
and draw valid conclusions from large
amounts of different types of data ranging
from genomics and metabolomics to
molecular dynamics in many single cells.
Effectively addressing this problem may
require new mathematical and computer
science approaches. A second key chal-
lenge is knowing what kind of measure-
ments to make and how accurate these
measurements need to be to fully under-
stand a biological system. Effectively
addressing this challenge will require a
re-evaluation of how measurements
have been made over the past 10 years
in systems biology (for instance, the
movement from two-hybrid interactions
to mass spectrometry to measure protein
interactions). It will also require the devel-
opment of even more sensitive strategies
to make time-dependent measurements
inside many cells simultaneously. Taken
together, systems biology is confronted
with the problem of both sensitivity and
scale.
Does the ultimate goal of synthetic bio-
logy of the predictable design, construc-
tion, and characterization of biological
systems rely on findings and approaches
from systems biology? Design, analysis,
and understanding are integrally linked in
engineering methodology. Therefore, it is
reasonable to assume that advances
Figure 1. The Challenges and Synergies for Systems and Synthetic
Biologygained through systems
biology in our understanding
of how biological compo-
nents interact to form inte-
grated systems will support
efforts in synthetic biology to
design engineered biological
systems. However, there is
a different viewpoint that
argues that the design princi-
ples that systems biologists
elucidate for natural biolog-
ical systems are products of
evolution over many millions
of years and thus are limited
by the history of what came
before. It is possible, then,
that the design principles
elucidated for natural biolog-
ical systems may not be
necessary or optimal for the
engineered systems that syn-
thetic biologists may design
from scratch on a computer
with less of a restriction of
generating new function
through evolutionary pro-
cesses and timescales. Bothof these views have merit, and the reality
is likely somewhere in between—even if
synthetic biologists design biological
systems to have certain properties that
are not generally found in natural systems
(i.e., optimized for troubleshooting,
tailoring, reuse, removal, designer identifi-
cation), a greater understanding of how
components interact to form integrated
systems will inform and support the
design process.
Synergy between Systems
and Synthetic Biology
Although synthetic biology did not directly
emerge from systems biology, there are
important parallels between the two
fields. Both systems biology and syn-
thetic biology represent fundamental
shifts in approaches from the fields they
grew out of. Whereas systems biology
represents a shift in the more traditional
reductionist approach taken in biological
research from studying components in
isolation to studying integrated compo-
nents, synthetic biology represents a shift
in emphasizing engineering principles and
methodology in building biological sys-
tems from more traditional genetic engi-
neering research. In addition, both fieldstake a bottom-up approach, with systems
biology emphasizing the understanding of
biological systems from the underlying
components and synthetic biology
emphasizing building biological systems
from modular components.
In examining the parallels between the
two fields, it is also useful to examine
how the key challenges each field is cur-
rently facing relate to one another (Fig-
ure 1). The challenges synthetic biologists
currently face in engineering genetic
systems can be classified as relating to
either limitations in understanding biolog-
ical systems or limitations in technical
capabilities to study biological systems.
The challenges systems biologists cur-
rently face in understanding biological
systems are related to the complexities
associated with studying natural biolog-
ical systems and the inadequacies of cur-
rent computational models to capture the
physical properties of biological systems.
We see several areas where these two
fields can be brought together to effec-
tively address these challenges.
The richness and complexity of engi-
neered genetic networks, which synthetic
biologists could build, will be advanced
by using the knowledge gained throughCell 144, March 18systems biology research.
For example, genome se-
quencing can provide an
increased diversity of biolog-
ical parts that synthetic biolo-
gists can use in their gene
circuit designs. More impor-
tantly, systems biology will
provide not just the physical
parts but a fundamental
understanding of how these
components can be inte-
grated effectively with other
components and how biolog-
ical systems integrate diverse
components and regulatory
mechanisms to achieve
robust information transmis-
sion and behaviors. The
importance of this contribu-
tion is highlighted by the
limited diversity of parts and
regulatory mechanisms that
have been integrated into
synthetic gene circuits to
date, in which the majority
of engineered systems rely
on a limited number of tran-scriptional regulators and do not exhibit
robust behaviors over different timescales
and environmental conditions (Elowitz
and Leibler, 2000; Gardner et al., 2000;
Purnick and Weiss, 2009). In order to
move toward the design of integrated
genetic systems, synthetic biologists will
need to design more sophisticated ge-
netic circuits that utilize diverse regulatory
strategies (specifically, the integration of
posttranscriptional and posttranslational
mechanisms), balance energetic load,
and dynamically modulate system be-
havior (Lim, 2010; Win et al., 2009).
Another important contribution of sys-
tems biology to synthetic biology is asso-
ciated with the technologies and tools for
analyzing biological systems. Synthetic
biologists often spend the bulk of their
effort in a design, characterization, and
optimization loop, where original designs
are modified based on characterization
data to achieve the desired system be-
havior. The tools developed by systems
biologists to study components in a sys-
tem and their interactions can be applied
to analyzing synthetic systems and trou-
bleshooting the system performance.
This is particularly true in cases in which
the synthetic gene network may have, 2011 ª2011 Elsevier Inc. 857
unanticipated effects on native pathways
in the cell that may in turn affect system
behavior. A common example of this chal-
lenge can arise in engineering metabolic
pathways, for which synthetic biologists
can use genome-wide profiling of tran-
script, protein, or metabolite levels to
identify undesired effects of introducing
the synthetic pathway in the host cell on
critical functions such as redox balance,
cofactor levels, and stress response
(Mukhopadhyay et al., 2008). As another
example, systems biologists have devel-
oped a variety of computational tools for
modeling biological systems and sharing
information on biological components
across different databases. These tools
will be useful foundations for synthetic
biologists looking to develop methods to
standardize and share information across
component libraries and develop com-
puter-aided design tools for biological
systems.
Advances in synthetic biology will
provide key contributions to systems
biology research by creating new tools
for interfacing with and manipulating bio-
logical systems. Research aimed at
understanding a biological system often
utilizes methods to perturb or manipulate
that system and examine the resulting
behavior of the modified system. Syn-
thetic biologists are developing novel
genetic devices that can be used by
systems biologists to interface with native
networks and precisely probe and manip-
ulate those systems. For example,
synthetic genetic devices have recently
been used to rewire signaling pathways
and create novel interactions between un-
related cellular components (Culler et al.,
2010; Lim, 2010). In addition, synthetic
biology can contribute strategies for
simplifying and isolating biological com-
ponents and their interactions through
the application of diverse approaches
for implementing specific component
interactions.
Synthetic biology can also provide new
simulation platforms for systems biology.
For example, systems biologists currently
develop mathematical models to repre-
sent the behavior of their systems and
use these models to predict the behavior
of their systems under different perturba-
tions and environments. However, the
development of these models often re-
quires assumptions that are imperfect858 Cell 144, March 18, 2011 ª2011 Elseviermatches for the physical model of a cell
(i.e., hard sphere, dilute gas models),
such that the ability of current computa-
tional models to capture system behavior
is limited at best. The potential advances
in constructing genetic systems coming
from synthetic biology research may
enable systems biologists to shift from
computational models to physical models
for their systems by implementing simula-
tions inside of cells. Specifically, scalable
and affordable DNA synthesis technology
can allow systems biologists to build
many modified versions of natural sys-
tems to test their understanding of those
systems.
Perspective of the Future
Moving forward, the synergy between
synthetic and systems biology will drive
transformative advances in biotech-
nology. The impact includes not only fur-
ther understanding of the complexity of
biological systems but the ability to use
this information to, for instance, design
better drugs, commodity manufacturing
processes, and cell-based therapies
(Ducat et al., 2011). As one example, the
complexity of biosynthesis processes
that can be engineered has been recently
advanced through the integration of a
number of pathway construction and
optimization tools, including genomic dis-
covery and engineering (Bayer et al.,
2009; Ro et al., 2006; Wang et al., 2009),
in vivo screens for enzyme activity
(Pfleger et al., 2006), and enzyme localiza-
tion strategies (Dueber et al., 2009).
Future efforts will focus on the develop-
ment of more advanced tools for biopro-
cess optimization, such as those enabling
noninvasive monitoring of pathway flux
(Win and Smolke, 2007), closed loop
embedded control of biosynthesis system
behavior (Dunlop et al., 2010; Farmer and
Liao, 2000), and biosynthesis compart-
mentalization and specialization. As ano-
ther example, systems engineering strat-
egies will play key roles in addressing
current challenges in cellular therapies
by enabling the programming of cell-fate
decisions (Culler et al., 2010), differenti-
ated states (Deans et al., 2007), improved
engraftment and targeting (Chen et al.,
2010), and effective kill switches (Callura
et al., 2010). Ultimately, researchers will
design systems that incorporate evolu-
tion—designing gene circuits that exhibitInc.desired, evolvable behaviors and eventu-
ally constructing ecosystems that exhibit
dynamic and predictable behavior
patterns.
However, it is important to look at
history in thinking about the promises
and risks of synthetic biology. Molecular
biology, and in particular the insertion of
foreign genes into microbes, was met
with circumspection by both the public
and scientific communities. At the time,
scientists made promises to the public—
for example, the production of human
insulin by engineered bacteria—and
delivered on at least some of these prom-
ises (Villa-Komaroff et al., 1978). So, what
can we expect from the interplay between
systems biology and synthetic biology in
the near and long term? In the near term,
we have already seen companies promise
to deliver on new fuels and carbon-based
products (such as plastics), and in 5 years
time this will be a partial reality, thereby
starting to take petroleum out of the
production loop. We believe that, in
10 years time, many high-value commod-
ities, including drugs, will be produced
biologically as the result of synthetic
biology efforts. In the much longer time
frame of 20 to 50 years, we hope that
synthetic biology will lead to new cell-
based therapies, the expansion of immu-
notherapy, synthetic organs and tissues,
and rebuilding devastated environments
and ecosystems.
These anticipated futures bring us to
the controversial areas in synthetic bio-
logy. How do we think about a future
that could involve the reprogramming of
entire organisms? Should we consider
engineering ecosystems to support sus-
tainable agriculture, environmental reme-
diation, and pathogen removal and to
treat human disease? How far should
and can we go in reprogramming life to
form new types of cells, tissues, and
entire organisms? These are only some
of the potential benefits and questions
scientists, engineers, policy makers,
governments, and, most importantly, the
public will need to ponder. Molecular
biologists set standards for safe use of
engineered organisms over 30 years
ago. However, as research in synthetic
biology is advancing toward the goals of
making biology easier to engineer, the
issues of safety and ethical use are being
revisited as we write this Essay. In fact,
a recent US government report captures
many of the critical issues around public
benefits and responsible stewardship
(Presidential Commission for the Study
of Bioethical Issues, 2010).
Although each field could in principle
exist without the other, we instead feel
that the natural interplay between design,
analysis, and understanding highlights
the important relationship between
systems biology and synthetic biology.
Systems biology brings added layers of
information that will further empower
future efforts to design synthetic biolog-
ical systems. Synthetic biology brings
new technologies and tools that can be
applied to effectively test our under-
standing of natural biological systems.
By integrating the contributions of these
rapidly evolving fields, scientists and
engineers together will be well positioned
to transform health, well-being, and the
environment in the years to come.ACKNOWLEDGMENTS
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